129 related articles for article (PubMed ID: 25665137)
1. Clinical outcome, PDGFRβ and KIT expression in feline histiocytic disorders: a multicentre study.
Treggiari E; Ressel L; Polton GA; Benoit J; Desmas I; Blackwood L
Vet Comp Oncol; 2017 Mar; 15(1):65-77. PubMed ID: 25665137
[TBL] [Abstract][Full Text] [Related]
2. Cytologic and immunocytochemical characterization of feline progressive histiocytosis.
Pinto da Cunha N; Ghisleni G; Scarampella F; Fabbrini F; Sforna M; Cornegliani L; Caniatti M; Avallone G; Moore P; Roccabianca P
Vet Clin Pathol; 2014 Sep; 43(3):428-36. PubMed ID: 24820657
[TBL] [Abstract][Full Text] [Related]
3. Feline progressive histiocytosis.
Affolter VK; Moore PF
Vet Pathol; 2006 Sep; 43(5):646-55. PubMed ID: 16966441
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of dysregulation of the receptor tyrosine kinases Kit, Flt3, and Met in histiocytic sarcomas of dogs.
Zavodovskaya R; Liao AT; Jones CL; Yip B; Chien MB; Moore PF; London CA
Am J Vet Res; 2006 Apr; 67(4):633-41. PubMed ID: 16579756
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical expression of c-KIT protein in feline soft tissue fibrosarcomas.
Smith AJ; Njaa BL; Lamm CG
Vet Pathol; 2009 Sep; 46(5):934-9. PubMed ID: 19429996
[TBL] [Abstract][Full Text] [Related]
6. Immunophenotyping of Nonneoplastic and Neoplastic Histiocytes in Cats and Characterization of a Novel Cell Line Derived From Feline Progressive Histiocytosis.
Hirabayashi M; Chambers JK; Sumi A; Harada K; Haritani M; Omachi T; Kobayashi T; Nakayama H; Uchida K
Vet Pathol; 2020 Nov; 57(6):758-773. PubMed ID: 32885737
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of Kit receptor tyrosine kinase dysregulations in feline cutaneous mast cell tumors.
Sabattini S; Guadagni Frizzon M; Gentilini F; Turba ME; Capitani O; Bettini G
Vet Pathol; 2013 Sep; 50(5):797-805. PubMed ID: 23377219
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of Minichromosome Maintenance Protein 7 and c-KIT as Prognostic Markers in Feline Cutaneous Mast Cell Tumours.
Dobromylskyj MJ; Rasotto R; Melville K; Smith KC; Berlato D
J Comp Pathol; 2015 Nov; 153(4):244-50. PubMed ID: 26385324
[TBL] [Abstract][Full Text] [Related]
9. A review of histiocytic diseases of dogs and cats.
Moore PF
Vet Pathol; 2014 Jan; 51(1):167-84. PubMed ID: 24395976
[TBL] [Abstract][Full Text] [Related]
10. Expression of molecular targets for tyrosine kinase receptor antagonists in malignant endocrine pancreatic tumors.
Fjällskog ML; Lejonklou MH; Oberg KE; Eriksson BK; Janson ET
Clin Cancer Res; 2003 Apr; 9(4):1469-73. PubMed ID: 12684421
[TBL] [Abstract][Full Text] [Related]
11. PDGFR-alpha as a potential therapeutic target in uterine sarcomas.
Adams SF; Hickson JA; Hutto JY; Montag AG; Lengyel E; Yamada SD
Gynecol Oncol; 2007 Mar; 104(3):524-8. PubMed ID: 17049587
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of imatinib mesylate (Gleevec) and immunohistochemical expression of c-Kit and PDGFR-beta in a Gynecologic Oncology Group Phase Il Trial in women with recurrent or persistent carcinosarcomas of the uterus.
Huh WK; Sill MW; Darcy KM; Elias KM; Hoffman JS; Boggess JF; Alvarez RD; Long HJ; O'Malley DM; Birrer MJ
Gynecol Oncol; 2010 May; 117(2):248-54. PubMed ID: 20189232
[TBL] [Abstract][Full Text] [Related]
13. Protein expression of KIT, BRAF, GNA11, GNAQ and RASSF1 in feline diffuse iris melanomas.
Rushton JG; Korb M; Kummer S; Reichart U; Fuchs-Baumgartinger A; Tichy A; Nell B
Vet J; 2019 Jul; 249():33-40. PubMed ID: 31239162
[TBL] [Abstract][Full Text] [Related]
14. Clinical snapshot. Cutaneous nodules in a cat.
Moriello KA
Compend Contin Educ Vet; 2007 Apr; 29(4):204, 240. PubMed ID: 17726849
[No Abstract] [Full Text] [Related]
15. Expression of KIT receptor in feline cutaneous mast cell tumors.
Rodriguez-Cariño C; Fondevila D; Segalés J; Rabanal RM
Vet Pathol; 2009 Sep; 46(5):878-83. PubMed ID: 19429979
[TBL] [Abstract][Full Text] [Related]
16. Feline progressive histiocytosis: a retrospective investigation of 26 cases and preliminary study of Ki67 as a prognostic marker.
Coste M; Prata D; Castiglioni V; Minoli L; Etienne-Raffestin CL; Boulouha L; Moreau S; Lagadic M
J Vet Diagn Invest; 2019 Nov; 31(6):801-808. PubMed ID: 31650906
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical expression of ionized calcium binding adapter molecule 1 in cutaneous histiocytic proliferative, neoplastic and inflammatory disorders of dogs and cats.
Pierezan F; Mansell J; Ambrus A; Rodrigues Hoffmann A
J Comp Pathol; 2014 Nov; 151(4):347-51. PubMed ID: 25172051
[TBL] [Abstract][Full Text] [Related]
18. Expression and mutational analysis of tyrosine kinase receptors c-kit, PDGFRalpha, and PDGFRbeta in ovarian cancers.
Wilczynski SP; Chen YY; Chen W; Howell SB; Shively JE; Alberts DS
Hum Pathol; 2005 Mar; 36(3):242-9. PubMed ID: 15791568
[TBL] [Abstract][Full Text] [Related]
19. [Expression and significance of C-kit and platelet-derived growth factor receptor-beta (PDGFRbeta) in esophageal carcinoma].
Zhang X; Rong TH; Zhang Y; Long H; Fu JH; Ling P; Zhang LJ; Yang MT; Zeng CG; Ma GW; Su XD; Li XD; Wang JY; Wen ZS; Zhao JM
Ai Zheng; 2006 Jan; 25(1):92-5. PubMed ID: 16405759
[TBL] [Abstract][Full Text] [Related]
20. [Reactive and neoplastic histiocytic diseases in the dog].
Schwens Ch; Thom N; Moritz A
Tierarztl Prax Ausg K Kleintiere Heimtiere; 2011; 39(3):176-90. PubMed ID: 22143627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
